Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T ...

Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of ...

Researchers are building on the success of CAR T therapy in blood cancers to explore its use in clear cell renal cell ...

The Food and Drug Administration has announced new guidelines that will make CAR T-cell therapy more accessible to cancer ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Mantle cell lymphoma treatment offers options if patients relapse after CAR T-cell therapy, from bispecific antibodies, antibody drug conjugates, and other emerging therapies.

Dr Dinesh Pendharkar highlights how CAR T–cell therapy is reshaping cancer care in India by equipping the immune system with ...

Months after announcing an M&A deal with AstraZeneca, EsoBiotec has released the first small slice of data on the cell ...

The discovery may explain why cutting edge CAR T-cell therapy has managed to revolutionized treatment for blood cancer but ...

CAR T-cell therapy: A groundbreaking cancer treatment using the patient's own immune system to fight and destroy cancer cells.

Explore the latest advancements in immunotherapies for T-cell lymphoma, addressing unique challenges and promising new ...